FASEB J. Integrated DNA Technologies
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published as doi: 10.1096/fj.06-7537com.
 (The FASEB Journal. 2007;21:1857-1869.)
© 2007 FASEB
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
fj.06-7537comv1
21/8/1857    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dogra, C.
Right arrow Articles by Kumar, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dogra, C.
Right arrow Articles by Kumar, A.

TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine

Charu Dogra*,1, Harish Changotra*,1, Nia Wedhas*,1, Xuezhong Qin*,{ddagger}, Jon E. Wergedal*,{ddagger} and Ashok Kumar*,{dagger},{ddagger},2

* Musculoskeletal Disease Center,

{dagger} Laboratory for Skeletal Muscle Physiology and Neurobiology, Jerry L. Pettis Memorial Veterans Administration Medical Center, Loma Linda, California, USA; and

{ddagger} Loma Linda University School of Medicine, Loma Linda, California, USA

2Correspondence: Laboratory for Skeletal Muscle Physiology and Neurobiology, Jerry L. Pettis Memorial Veterans Administration Medical Center, 11201 Benton St. (151), Loma Linda, CA 92357, USA. E-mail: ashok.kumar2{at}va.gov

TWEAK cytokine has been implicated in several biological responses including inflammation, angiogenesis, and osteoclastogenesis. We have investigated the role of TWEAK in regulating skeletal muscle mass. Addition of soluble TWEAK protein to cultured myotubes reduced the mean myotube diameter and enhanced the degradation of specific muscle proteins such as CK and MyHCf. The effect of TWEAK on degradation of MyHCf was stronger than its structural homologue, TNF-{alpha}. TWEAK increased the ubiquitination of MyHCf and the transcript levels of atrogin-1 and MuRF1 ubiquitin ligases. TWEAK inhibited phosphorylation of Akt kinase and its downstream targets GSK-3ß, FOXO1, mTOR, and p70S6K. Furthermore, TWEAK increased the activation of NF-{kappa}B transcription factor in myotubes. Adenoviral-mediated overexpression of I{kappa}B{alpha}{Delta}N (a degradation-resistant mutant of NF-{kappa}B inhibitory protein I{kappa}B{alpha}) in myotubes blocked the TWEAK-induced degradation of MyHCf. Chronic administration of TWEAK in mice resulted in reduced body and skeletal muscle weight with an associated increase in the activity of ubiquitin-proteasome system and NF-{kappa}B. Finally, muscle-specific transgenic overexpression of TWEAK decreased the body and skeletal muscle weight in mice. Collectively, our data suggest that TWEAK induces skeletal muscle atrophy through inhibition of the PI3K/Akt signaling pathway and activation of the ubiquitin-proteasome and NF-{kappa}B systems.—Dogra, C., Changotra, H., Wedhas, N., Qin, X., Wergedal, J. E., Kumar, A. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine.


Key Words: skeletal muscle atrophy • atrogin-1 • MuRF1 • NF-{kappa}B • Akt




This article has been cited by other articles:


Home page
 EndocrinologyHome page
G. Tiller, P. Fischer-Posovszky, H. Laumen, A. Finck, T. Skurk, M. Keuper, U. Brinkmann, M. Wabitsch, D. Link, and H. Hauner
Effects of TWEAK (TNF Superfamily Member 12) on Differentiation, Metabolism, and Secretory Function of Human Primary Preadipocytes and Adipocytes
Endocrinology, December 1, 2009; 150(12): 5373 - 5383.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. J. Carrero and P. Stenvinkel
Persistent Inflammation as a Catalyst for Other Risk Factors in Chronic Kidney Disease: A Hypothesis Proposal
Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S49 - S55.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
S. H. Lecker
Given the Science on Malnutrition, How Does the Clinician Respond? Practical Lessons for and Application to the Dialysis Patient
Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S64 - S70.
[Full Text] [PDF]

Home page
 Eur J Heart FailHome page
E. Chorianopoulos, M. Rosenberg, C. Zugck, J. Wolf, H. A. Katus, and N. Frey
Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure
Eur J Heart Fail, November 1, 2009; 11(11): 1050 - 1056.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
S. P. Fortin, M. J. Ennis, B. A. Savitch, D. Carpentieri, W. S. McDonough, J. A. Winkles, J. C. Loftus, C. Kingsley, G. Hostetter, and N. L. Tran
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Stimulation of Glioma Cell Survival Is Dependent on Akt2 Function
Mol. Cancer Res., November 1, 2009; 7(11): 1871 - 1881.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. U. Trendelenburg, A. Meyer, D. Rohner, J. Boyle, S. Hatakeyama, and D. J. Glass
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
Am J Physiol Cell Physiol, June 1, 2009; 296(6): C1258 - C1270.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Kumar, D. Y. Makonchuk, H. Li, A. Mittal, and A. Kumar
TNF-Like Weak Inducer of Apoptosis (TWEAK) Activates Proinflammatory Signaling Pathways and Gene Expression through the Activation of TGF-{beta}-Activated Kinase 1
J. Immunol., February 15, 2009; 182(4): 2439 - 2448.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Li, A. Mittal, P. K. Paul, M. Kumar, D. S. Srivastava, S. C. Tyagi, and A. Kumar
Tumor Necrosis Factor-related Weak Inducer of Apoptosis Augments Matrix Metalloproteinase 9 (MMP-9) Production in Skeletal Muscle through the Activation of Nuclear Factor-{kappa}B-inducing Kinase and p38 Mitogen-activated Protein Kinase: A POTENTIAL ROLE OF MMP-9 IN MYOPATHY
J. Biol. Chem., February 13, 2009; 284(7): 4439 - 4450.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. J. Carrero, A. Ortiz, A. R. Qureshi, J. L. Martin-Ventura, P. Barany, O. Heimburger, B. Marron, G. Metry, S. Snaedal, B. Lindholm, et al.
Additive Effects of Soluble TWEAK and Inflammation on Mortality in Hemodialysis Patients
Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 110 - 118.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
J. S. Moylan, J. D. Smith, M. A. Chambers, T. J. McLoughlin, and M. B. Reid
TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling
Am J Physiol Cell Physiol, October 1, 2008; 295(4): C986 - C993.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
M. Sandri
Signaling in Muscle Atrophy and Hypertrophy
Physiology, June 1, 2008; 23(3): 160 - 170.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. J. Crozier, M. D. Sans, C. H. Lang, L. G. D'Alecy, S. A. Ernst, and J. A. Williams
CCK-induced pancreatic growth is not limited by mitogenic capacity in mice
Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1148 - G1157.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. K. Srivastava, X. Qin, N. Wedhas, M. Arnush, T. A. Linkhart, R. B. Chadwick, and A. Kumar
Tumor Necrosis Factor-{alpha} Augments Matrix Metalloproteinase-9 Production in Skeletal Muscle Cells through the Activation of Transforming Growth Factor- -activated Kinase 1 (TAK1)-dependent Signaling Pathway
J. Biol. Chem., November 30, 2007; 282(48): 35113 - 35124.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The Federation of American Societies for Experimental Biology.